- Home
- ADVB vs PMVP Comparison
ADVB vs PMVP Comparison
Compare ADVB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- PMVP
- Stock Information
- Founded
- ADVB 2014
- PMVP 2013
- Country
- ADVB United States
- PMVP United States
- Employees
- ADVB N/A
- PMVP N/A
- Industry
- ADVB Medical Specialities
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ADVB Health Care
- PMVP Health Care
- Exchange
- ADVB Nasdaq
- PMVP Nasdaq
- Market Cap
- ADVB 12.2M
- PMVP 76.8M
- IPO Year
- ADVB 2025
- PMVP 2020
- Fundamental
- Price
- ADVB $0.43
- PMVP $1.59
- Analyst Decision
- ADVB
- PMVP Strong Buy
- Analyst Count
- ADVB 0
- PMVP 1
- Target Price
- ADVB N/A
- PMVP $5.00
- AVG Volume (30 Days)
- ADVB 930.8K
- PMVP 726.8K
- Earning Date
- ADVB 10-27-2025
- PMVP 11-07-2025
- Dividend Yield
- ADVB N/A
- PMVP N/A
- EPS Growth
- ADVB N/A
- PMVP N/A
- EPS
- ADVB N/A
- PMVP N/A
- Revenue
- ADVB N/A
- PMVP N/A
- Revenue This Year
- ADVB N/A
- PMVP N/A
- Revenue Next Year
- ADVB N/A
- PMVP N/A
- P/E Ratio
- ADVB N/A
- PMVP N/A
- Revenue Growth
- ADVB N/A
- PMVP N/A
- 52 Week Low
- ADVB $0.34
- PMVP $0.81
- 52 Week High
- ADVB $4.10
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- ADVB 47.01
- PMVP 62.95
- Support Level
- ADVB $0.42
- PMVP $1.38
- Resistance Level
- ADVB $0.62
- PMVP $1.50
- Average True Range (ATR)
- ADVB 0.06
- PMVP 0.11
- MACD
- ADVB 0.00
- PMVP 0.02
- Stochastic Oscillator
- ADVB 21.44
- PMVP 78.40
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.